Embecta (Nasdaq:EMBC) announced today that it entered into a definitive agreement to acquire Owen Mumford Holdings Limited. Owen Mumford, a privately held, UK-based company, develops and manufactures medical devices and drug delivery technologies. Embecta, the former BD Diabetes business, agreed to acquire Owen Mumford with an upfront cash payment of approximately $133 million (£100 million). […]
Wall Street Beat
MiniMed completes $538M IPO, retains $309M in proceeds as Medtronic separation takes shape
MiniMed (Nasdaq:MMED) announced today that it completed its previously announced initial public offering (IPO). Shares of MMED began trading on Friday, March 6, following the pricing of the IPO that day. They closed today, March 9, down 2.7% at $18 apiece. The Medtronic Diabetes unit priced its IPO at $20 per share, offering 28 million […]
MiniMed expects to close $644M IPO next week ahead of Medtronic split
MiniMed has set the price for its planned initial public offering (IPO) ahead of an imminent separation from Medtronic (NYSE:MDT). The Medtronic Diabetes unit’s IPO includes 28 million shares of common stock priced at $20 apiece, amounting to $560 million. Underwriters also have an option to purchase up to 4.2 million additional shares at the […]
Senseonics earns FDA IDE for next-gen Gemini CGM, posts Q4 revenue beat
Senseonics (NYSE:SENS) posted fourth-quarter results that proved mixed compared to Wall Street forecasts alongside a major pipeline announcement. Along with its fourth-quarter results, the company shared that it secured FDA investigational device exemption (IDE) for its self-powered, battery-enabled Gemini sensor. It enrolled the first patients in the IDE trial and expects to complete that in […]
Tandem Diabetes Care prices upsized $265M offering
Tandem Diabetes Care (Nasdaq:TNDM) today announced the pricing of a $265 million offering of convertible senior notes. San Diego-based Tandem earlier this week announced its intent to offer $200 million in notes, due 2032, in a private placement. It now says it upsized that offering by $65 million. The company also granted initial purchasers an […]
Medtronic MiniMed Diabetes IPO could reach up to $784M
In an amendment to an SEC filing, Medtronic’s (NYSE:MDT) Diabetes unit, MiniMed, today shared more details on its planned initial public offering (IPO). Medtronic announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company. In that announcement, the company projected the separation within the next 18 months. It […]
Tandem Diabetes Care announces $200M notes offering
This article ran on Monday, Feb. 23, 2026. On Wednesday, Feb. 25, 2026, Tandem announced the upsized pricing of the offering. Read the updated article here. Tandem Diabetes Care (Nasdaq:TNDM) announced today that it intends to offer $200 million in convertible senior notes, due in 2032. San Diego-based Tandem said it plans to offer […]
ICU Medical resolves Smiths Medical warning letter, posts mixed Q4
ICU Medical (Nasdaq:ICUI) shares dipped slightly today on fourth-quarter results that were mixed compared to the consensus forecast. Shares of ICUI fell 1.25% to $149.74 apiece in early-morning trading today. The San Clemente, California-based infusion technology and critical care product provider reported losses of $15.7 million. That equals 64¢ per share on sales of $540.7 […]
Tandem stock rises on Q4 beats, new pay-as-you-go model
Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of TNDM rose 11.5% to $20.65 apiece after the market closed today. The San Diego-based automated insulin delivery technology developer reported losses of 589 million. That equals 1¢ per share on sales of $290.4 […]
Insulet stock rises before hours on Street-beating Q4, 31% sales growth
Insulet (Nasdaq:PODD) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast. Shares of PODD ticked up more than 8% to $266.10 apiece in morning trading today. The Acton, Massachusetts–based automated insulin delivery technology developer reported profits of $101.6 million. That equals $1.44 per share on sales of $783.8 […]
